Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022).

MLA

Gazda, Agnieszka, et al. “Clinical Outcomes of Tocilizumab Therapy in Polyarticular and Systemic Juvenile Idiopathic Arthritis: A Single-Center Analysis (2018-2022).” Rheumatology International, Sept. 2024. EBSCOhost, https://doi.org/10.1007/s00296-024-05711-4.

APA

Gazda, A., Naishtetik, I., Kołodziejczyk, B., Rybak, K., Mańczak, M., Wójtowicz, J., Krasowicz-Towalska, O., & Gietka, P. (2024). Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022). Rheumatology International. https://doi.org/10.1007/s00296-024-05711-4

Chicago

Gazda, Agnieszka, Iryna Naishtetik, Beata Kołodziejczyk, Khrystyna Rybak, Małgorzata Mańczak, Joanna Wójtowicz, Olga Krasowicz-Towalska, and Piotr Gietka. 2024. “Clinical Outcomes of Tocilizumab Therapy in Polyarticular and Systemic Juvenile Idiopathic Arthritis: A Single-Center Analysis (2018-2022).” Rheumatology International, September. doi:10.1007/s00296-024-05711-4.